Future Novel Imaging Methods
Glaucoma is an ocular disease resulting in irreversible vision loss. It is estimated more than 60 million people worldwide have glaucoma and its incidence is anticipated to increase to more than 111 million by 2040. Glaucoma causes damage to the optic ner
- PDF / 10,398,910 Bytes
- 129 Pages / 504.63 x 737.01 pts Page_size
- 36 Downloads / 221 Views
Rohit Varma Benjamin Y. Xu Grace M. Richter Alena Reznik Editors
Advances in Ocular Imaging in Glaucoma
Essentials in Ophthalmology Series Editor Arun D. Singh
More information about this series at http://www.springer.com/series/5332
Rohit Varma • Benjamin Y. Xu Grace M. Richter • Alena Reznik Editors
Advances in Ocular Imaging in Glaucoma
Editors Rohit Varma, MD, MPH Keck School of Medicine of USC University of Southern California Los Angeles, CA USA Grace M. Richter, MD, MPH Keck School of Medicine of USC University of Southern California Los Angeles, CA USA
Benjamin Y. Xu, MD, PhD Keck School of Medicine of USC University of Southern California Los Angeles, CA USA Alena Reznik, MD Southern California Eye Institute CHA Hollywood Presbyterian Medical Center Los Angeles, CA USA
ISSN 1612-3212 ISSN 2196-890X (electronic) Essentials in Ophthalmology ISBN 978-3-030-43846-3 ISBN 978-3-030-43847-0 (eBook) https://doi.org/10.1007/978-3-030-43847-0 © Springer Nature Switzerland AG 2020 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
Traditionally, a glaucoma specialist simply performed gonioscopy, funduscopic optic disc examination, and visual field testing to diagnose and monitor disease progression. However, imaging technology from ultrasonography to optical coherence tomography (OCT) and beyond has demonstrated the vital role of such technological advancements in providing the best possible care for our glaucoma patients. The masses of literature to date in each area of glaucoma imaging technology can be overwhelming to even a glaucoma subspecialist. This book aims to serve as a primer on best practices for clinical integration of imaging technologies, interpreta
Data Loading...
